By Argyll Cyrus Geducos
The Department of Health (DOH) urged the people behind the acquisition of the Dengue P3.5 vaccine Billion to explain to his side to avoid any unnecessary speculation.
Secretary of Health Francisco Duque III (AP Photo / Aaron Favila / MANILA BULLETIN)
The DOH also seeks a refund of said amount after the manufacturer of Dengvaxia Sanofi-Pasteur revealed that the vaccine could worsen the effects of the disease in those who have not been exposed to the dengue virus.
Health Secretary Francisco Duque III said that the people behind the now-controversial dengue immunization program should be presented, including former president Benigno Aquino III and former Health Secretary Janet Garin.
"It really depends on them if they wanted to clarify several issues on the issue because they were the ones who made the vital decision to acquire the vaccines," Duque said during the Bangon Marawi Task Force in Malacañang on Friday.
If they do not, "there will be too much speculation and sometimes there are hints, very toxic speculations," he continued.
Duke also granted Aquino, Garin and others behind the controversial program the benefit of the doubt, saying he is sure they did not intend to compromise public safety.
I'm sure they really meant well. I have no doubt that they had good intentions. So to prevent it from turning into a snowball, it could be good, sabihin na lang kung ano talaga (just to tell what really happened), "he said.
" The [former] Chairman and the head of the Department [former] were guided in the comments and in the documentary evidence that the WHO guidelines were in fact followed, "he added.
The three guidelines that Duque referred to are: Give vaccines to communities where the 70 percent of the population was exposed to dengue, the government should administer the vaccine to people aged 9 to 45, and that these people should receive three vaccines to complete the program.
Garin in Paris  Meanwhile, Duke also gave Garin the benefit of the doubt when reports surfaced that the former Health Secretary went to Paris, France to meet the best gentlemen of Sanofi.
"Well, I also heard that . But it is difficult to guess the former Secretary of Health and also the former President, "he said.
He added that it is too early to comment on whether Aquino and Garin should or should not charge for this anomaly related to dengue vaccines. past.
Duke, despite reports that the government plans to file a case against Sanofi, refused to disclose information related to the matter.
He said the The Senate and the House of Representatives will conduct their investigation on the matter on Monday and Wednesday, respectively.
He also noted that the Department of Justice (DOJ) has already ordered that the National Bureau of Investigation (NBI) conduct a survey of depth about those who could be held accountable.
"We will have to wait while the investigation progresses. I am sure that part of the information will be revealed, "said Duque
" But DOH, for its part, has to cooperate here. It will certainly provide important and relevant documents. "
Origin of funds
Duque, since he was only Secretary of Health for one month, was not familiar with the way in which the acquisition of the funds was made. financed vaccines.
"Originally, the source was the income collected from sin taxes. Yes. And I think there was a saving. It's a kind of irregular information that I have, but there was the money, yes, "he said.
He said he does not think the money used to purchase the vaccines was part of the DOH budget and stated that the Filipino Children's Medical Center (PCMC) was in charge of buying vaccines.
"It is not PCMC's budget. It is a budget that was given to PCMC because the instruction was to make the acquisition. But we do not know the origin fund. "
" I'm sure all of these will emerge once the investigation is started, "he continued.
Tags: controversial program, vaccine against dengue, dengue virus, DOH, DOH urges people behind the purchase of Dengvaxia P3.5-B to explain the side, Secretary of Health Francisco Duque III, Manila Bulletin, acquisitions, speculations